Form 4 for ANIX Anixa Biosciences Inc
Accepted 2021-07-19 00:00:00 ET · period of report 2021-07-15 · accession 0001493152-21-017157 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2021-07-19 | 2021-07-15+ | ANIX | Titterton Lewis H jr | Dir | P - Purchase | $3.99 | +12.2K | 905.8K | +1% | +$48.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-07-15 | P | A | 2,200 | $3.65 | 895,826 | D | — | — | |
| 2 | Common | Common Stock | 2021-07-16 | P | A | 10,000 | $4.07 | 905,826 | D | — | — |